Emergent Biosolutions Inc (EBS)
EBITDA Margin
-0.09%
TTM · Period ending:
EBS EBITDA Margin
Latest reported-0.09%period ending
Latest reported-0.09%period ending
EBS TTM EBITDA Margin (-29.60% → -0.09%)
TTM ebitda margin
High-resolution chart · PNG
EBS ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -0.0909% | |
| 22.6064% | |
| 32.0232% | |
| 34.4911% | |
| 32.21% | |
| 12.6683% | |
| 5.1552% | |
| 1.7326% | |
| -4.9447% | |
| 10.545% | |
| -4.0313% | |
| 0.807% | |
| -2.6112% | |
| -10.972% | |
| 3.0336% | |
| 22.7673% | |
| 22.2118% | |
| 24.7155% | |
| 29.1014% | |
| 27.8669% | |
| 33.9849% | |
| 40.231% | |
| 37.1801% | |
| 30.5212% | |
| 30.659% | |
| 22.6631% | |
| 21.0575% | |
| 16.0577% | |
| 11.2167% | |
| 18.2662% | |
| 20.4006% | |
| 26.6381% | |
| 31.219% | |
| 27.0799% | |
| 31.1681% | |
| 32.6852% | |
| 31.3717% | |
| 29.6246% | |
| 31.5554% | |
| 34.5633% | |
| 37.835% | |
| 44.575% | |
| 38.1492% | |
| 34.1584% | |
| 28.7505% | |
| 21.5388% | |
| 21.9979% | |
| 18.7001% | |
| 16.547% | |
| 18.777% | |
| 22.3099% | |
| 18.6274% | |
| 16.3458% | |
| 14.5891% | |
| 14.1808% | |
| 21.5483% | |
| 19.1054% | |
| 21.3837% | |
| 15.1084% | |
| 11.1898% | |
| 16.9784% | |
| 15.866% | |
| 27.6094% | |
| 20.2215% | |
| 11.4089% | |
| 15.0032% | |
| 19.8125% | |
| 19.8291% | |
| 26.3685% | |
| 20.3676% | |
| 19.5515% | |
| 33.134% | |
| 30.1163% | |
| 27.2026% | |
| 20.0333% | |
| 20.8779% | |
| 27.381% | |
| 46.3401% | |
| 65.109% | |
| 13.7779% | |
| 29.0388% | |
| 33.0662% | |
| 36.6611% | |
| 34.5464% | |
| 29.2323% | |
| 22.979% | |
| 15.5135% | |
| -0.63% | |
| -8.276% | |
| -36.5081% | |
| -29.5993% | |
| -29.5993% |